Week 431 Review - Dreadful week as all my large holdings drop

A pretty bad week for almost everything, with the gap between cost and value widening by £3,268 to £88,462 and total value dropping to £112,899.

Worst performer was SBTX:SkinBioTherapeutics which fell 15%, which is deeply upsetting after my recent big purchase.

CWR:Ceres Power has been an utter disaster and fell another 14% to go 33% down in just a few weeks.

JLP:Jubilee Metals is one of my largest holdings and continues to drop, this week by 6% to go below 5p.

SAE:Simec Atlantis Energy also fell 6% for no particular reason.

ANTO:Antofagasta dropped 5% to go 15% down.

EDV:Endeavour Mining also dropped 5% but fortunately my recent purchase is still just in profit.

OPTI:Optibiotix continued to slide with another 5% drop contributing to much of the losses this week.

Only one share rose more than 5% so BLU:Blue Star Capital gets Share of the Week rising 38%, but I suspect it's just shorts closing as there's no reason for it to go up.

Here's the ISA and shares portfolio after week 15 of year 9.

			Weekly Change
Cash	£169.40		+£26.58
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£53,745.77	(-45.8%)	-£3,268.08
Potential profits	£2,786.34		-£1,142.87
Yr 9 Dividends	£146.90		+£25.71
Yr 9 Interest	£2.46		+£0.87
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£42.01	(0.7%)	+£6.10
Total Dividends	£12,058.33		+£25.71
Total Interest	£4.39		+£0.87
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£292.52	(5.0%)	-£0.42
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I received a £25 dividend from PLUS:Plus 500 and 87p interest. Big drop in portfolio value and most of reduced potential profits were due to OPTI:Optibiotix.

Hope this doesn't become a trend!

Almost down to the trend line - let's hope we don't cross it

The SIPP looks like this after week 415 overall and week 51 of year 8.

			Weekly Change
Cash	£353.26		+£0.46
Portfolio cost	£99,680.94		+£249.92
Portfolio sell value (bid price - commission)	£57,408.34	(-42.7%)	-£2,542.45
Potential profits	£4,071.03		-£358.24
Yr 8 Dividends	£492.10		+£0
Yr 8 Interest	£5.68		+£0.46
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£786.76	(-13.9%)	+£15.77
Total Dividends	£14,634.88		+£0
Total Interest	£5.93		+£0.46
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£253.95	(4.5%)	-£0.61
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Similar story to the ISA except with no dividend. My regular investment went through, purchasing 91 shares in AJB:AJ Bell at 271.6296p costing £249.92. Just one more week to go and I'll be able to wave goodbye to the depressing DDDD:4D Pharma loss haunting me every week for Year 8.

Seems less of a drop than the ISA

A little more of a buffer to the trend line than the ISA

The trading account looks like this after week 381 overall and week 17 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£941.02	(-47.6%)	-£24.21
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£74.57	(+49.9%)	-£4.66
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.57	(-4.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Yet another drop. Nothing more to say.

Long term decline.

I'm amazed the trend line isn't flatter by now, but I can't see a £300 reversal in fortune to get back anywhere near it, so it will flatten quickly.

This was a catch up from when I was on hols and managed to take the weekly snapshots. Another 2 weeks of catch-ups to write before we're up to date...